References
References
1. Beavis, P.A., et al., CD73: a potent suppressor of antitumor immune responses. Trends Immunol, 2012. 33(5): p. 231-7.
2. Stagg, J., et al., Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci U S A, 2010. 107(4): p. 1547-52.
Keywords:
CD73,
adenosine receptor antagonists,
metastasis,
cancer immunotherapy,
tumour immunology,
mouse models
Conference:
15th International Congress of Immunology (ICI), Milan, Italy, 22 Aug - 27 Aug, 2013.
Presentation Type:
Abstract
Topic:
Translational immunology and immune intervention
Citation:
Beavis
PA,
Divisekera
U,
Paget
C,
Chow
M,
John
LB,
Stagg
J,
Smyth
MJ and
Darcy
PK
(2013). Adenosine receptor blockade potently suppresses the metastasis of CD73+ tumours.
Front. Immunol.
Conference Abstract:
15th International Congress of Immunology (ICI).
doi: 10.3389/conf.fimmu.2013.02.00711
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
14 Jun 2013;
Published Online:
22 Aug 2013.
*
Correspondence:
Dr. Paul A Beavis, Peter MacCallum Cancer Centre, Melbourne, Australia, paul.beavis@petermac.org
Prof. Phillip K Darcy, Peter MacCallum Cancer Centre, Melbourne, Australia, Phil.darcy@petermac.org